Pediatric rheumatology patients cannot access approved treatments due to access barriers

Children with rheumatic conditions have effective treatments available, but face critical delays and barriers in obtaining them when medically urgent. Parents and pediatric rheumatologists struggle with insurance denials, prior authorization delays, and supply chain issues that prevent timely treatment initiation, leading to preventable long-term joint damage and disability in children.